Eli Lilly (LLY) Gross Margin (2009 - 2026)
Eli Lilly posted quarterly Gross Margin of 81.93% for Q1 2026, down 59.0% year-on-year from 199.84% in Q1 2025, and down 0.71% on a QoQ basis from 82.52% in Q4 2025.
Eli Lilly (LLY) has 18 years of Gross Margin data on file, last reported at 81.93% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 59.0% year-over-year to 81.93%; the trailing twelve-month figure through Mar 2026 stood at 82.83% (up 113.0% YoY), and the FY2025 full-year result was 83.04%, up 173.0% from the prior year.
- Gross Margin for Q1 2026 stood at 81.93%, down from 82.52% in the prior quarter.
- Across five years, Gross Margin topped out at 84.27% in Q2 2025 and bottomed at 73.47% in Q1 2022.
- The 5-year median for Gross Margin is 80.89% (2023), against an average of 80.16%.
- Peak annual rise in Gross Margin reached 693 bps in 2022, while the deepest fall reached 162 bps in 2022.
- A 5-year view of Gross Margin shows it stood at 78.8% in 2022, then climbed by 3 bps to 80.89% in 2023, then advanced by 2 bps to 82.24% in 2024, then advanced by 0 bps to 82.52% in 2025, then slipped by 1 bps to 81.93% in 2026.
- The last three Gross Margin figures came in at 81.93% (Q1 2026), 82.52% (Q4 2025), and 82.91% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 81.93% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 66.31% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 71.88% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 74.24% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 68.16% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 79.24% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -51.69% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 70.22% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.93% |
| Dec 31, 2025 | 82.52% |
| Sep 30, 2025 | 82.91% |
| Jun 30, 2025 | 84.27% |
| Mar 31, 2025 | 82.52% |
| Dec 31, 2024 | 82.24% |
| Sep 30, 2024 | 81.02% |
| Jun 30, 2024 | 80.80% |
| Mar 31, 2024 | 80.91% |
| Dec 31, 2023 | 80.89% |
| Sep 30, 2023 | 80.42% |
| Jun 30, 2023 | 78.26% |
| Mar 31, 2023 | 76.63% |
| Dec 31, 2022 | 78.80% |
| Sep 30, 2022 | 77.25% |
| Jun 30, 2022 | 77.95% |
| Mar 31, 2022 | 73.47% |
| Dec 31, 2021 | 74.37% |
| Sep 30, 2021 | 78.87% |
| Jun 30, 2021 | 71.02% |
| Mar 31, 2021 | 72.40% |
| Dec 31, 2020 | 76.88% |
| Sep 30, 2020 | 76.89% |
| Jun 30, 2020 | 77.78% |
| Mar 31, 2020 | 79.26% |
| Dec 31, 2019 | 79.02% |
| Sep 30, 2019 | 78.55% |
| Jun 30, 2019 | 80.04% |
| Mar 31, 2019 | 77.64% |
| Dec 31, 2018 | 79.96% |
| Sep 30, 2018 | 78.28% |
| Jun 30, 2018 | 77.90% |
| Mar 31, 2018 | 76.54% |
| Dec 31, 2017 | 73.30% |
| Sep 30, 2017 | 71.96% |
| Jun 30, 2017 | 73.01% |
| Mar 31, 2017 | 74.22% |
| Dec 31, 2016 | 74.55% |
| Sep 30, 2016 | 73.02% |
| Jun 30, 2016 | 72.89% |
| Mar 31, 2016 | 72.81% |
| Dec 31, 2015 | 74.16% |
| Sep 30, 2015 | 75.06% |
| Jun 30, 2015 | 75.53% |
| Mar 31, 2015 | 74.32% |
| Dec 31, 2014 | 75.53% |
| Sep 30, 2014 | 74.01% |
| Jun 30, 2014 | 75.90% |
| Mar 31, 2014 | 73.89% |
| Dec 31, 2013 | 76.13% |
| Sep 30, 2013 | 79.25% |
| Jun 30, 2013 | 80.35% |
| Mar 31, 2013 | 79.32% |
| Dec 31, 2012 | 79.05% |
| Sep 30, 2012 | 77.89% |
| Jun 30, 2012 | 79.53% |
| Mar 31, 2012 | 78.62% |
| Dec 31, 2011 | 78.14% |
| Sep 30, 2011 | 78.23% |
| Jun 30, 2011 | 80.36% |
| Mar 31, 2011 | 79.79% |
| Dec 31, 2010 | 80.08% |
| Sep 30, 2010 | 82.00% |
| Jun 30, 2010 | 81.68% |
| Mar 31, 2010 | 79.54% |
| Dec 31, 2009 | 75.88% |
| Sep 30, 2009 | 80.47% |
| Jun 30, 2009 | 82.10% |
| Mar 31, 2009 | 83.82% |